214 related articles for article (PubMed ID: 30188117)
1. P-Glycoprotein-Targeted Photothermal Therapy of Drug-Resistant Cancer Cells Using Antibody-Conjugated Carbon Nanotubes.
Suo X; Eldridge BN; Zhang H; Mao C; Min Y; Sun Y; Singh R; Ming X
ACS Appl Mater Interfaces; 2018 Oct; 10(39):33464-33473. PubMed ID: 30188117
[TBL] [Abstract][Full Text] [Related]
2. P-glycoprotein targeted photodynamic therapy of chemoresistant tumors using recombinant Fab fragment conjugates.
Mao C; Qu P; Miley MJ; Zhao Y; Li Z; Ming X
Biomater Sci; 2018 Oct; 6(11):3063-3074. PubMed ID: 30298866
[TBL] [Abstract][Full Text] [Related]
3. P-glycoprotein targeted and near-infrared light-guided depletion of chemoresistant tumors.
Mao C; Zhao Y; Li F; Li Z; Tian S; Debinski W; Ming X
J Control Release; 2018 Sep; 286():289-300. PubMed ID: 30081143
[TBL] [Abstract][Full Text] [Related]
4. P-glycoprotein-targeted photodynamic therapy boosts cancer nanomedicine by priming tumor microenvironment.
Mao C; Li F; Zhao Y; Debinski W; Ming X
Theranostics; 2018; 8(22):6274-6290. PubMed ID: 30613297
[TBL] [Abstract][Full Text] [Related]
5. Poly(ethylene glycol)-conjugated multi-walled carbon nanotubes as an efficient drug carrier for overcoming multidrug resistance.
Cheng J; Meziani MJ; Sun YP; Cheng SH
Toxicol Appl Pharmacol; 2011 Jan; 250(2):184-93. PubMed ID: 20970441
[TBL] [Abstract][Full Text] [Related]
6. Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein.
Sikic BI; Fisher GA; Lum BL; Halsey J; Beketic-Oreskovic L; Chen G
Cancer Chemother Pharmacol; 1997; 40 Suppl():S13-9. PubMed ID: 9272128
[TBL] [Abstract][Full Text] [Related]
7. Multidrug resistance: molecular mechanisms and clinical relevance.
Ling V
Cancer Chemother Pharmacol; 1997; 40 Suppl():S3-8. PubMed ID: 9272126
[TBL] [Abstract][Full Text] [Related]
8. A comparison of rhodamine 123 accumulation and efflux in cells with P-glycoprotein-mediated and MRP-associated multidrug resistance phenotypes.
Twentyman PR; Rhodes T; Rayner S
Eur J Cancer; 1994; 30A(9):1360-9. PubMed ID: 7999426
[TBL] [Abstract][Full Text] [Related]
9. Targeting multidrug resistant tumor cells with a recombinant single-chain FV fragment directed to P-glycoprotein.
Niv R; Assaraf YG; Segal D; Pirak E; Reiter Y
Int J Cancer; 2001 Dec; 94(6):864-72. PubMed ID: 11745490
[TBL] [Abstract][Full Text] [Related]
10. P-glycoprotein confers methotrexate resistance in 3T6 cells with deficient carrier-mediated methotrexate uptake.
de Graaf D; Sharma RC; Mechetner EB; Schimke RT; Roninson IB
Proc Natl Acad Sci U S A; 1996 Feb; 93(3):1238-42. PubMed ID: 8577747
[TBL] [Abstract][Full Text] [Related]
11. Carbon nanotubes for delivery of small molecule drugs.
Wong BS; Yoong SL; Jagusiak A; Panczyk T; Ho HK; Ang WH; Pastorin G
Adv Drug Deliv Rev; 2013 Dec; 65(15):1964-2015. PubMed ID: 23954402
[TBL] [Abstract][Full Text] [Related]
12. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
Gu J; Fang X; Hao J; Sha X
Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic effect of the cyclosporin PSC 833 in multidrug-resistant leukaemia cells with increased expression of P-glycoprotein.
Lehne G; Rugstad HE
Br J Cancer; 1998 Sep; 78(5):593-600. PubMed ID: 9744497
[TBL] [Abstract][Full Text] [Related]
14. P-glycoprotein as a drug target in the treatment of multidrug resistant cancer.
Lehne G
Curr Drug Targets; 2000 Jul; 1(1):85-99. PubMed ID: 11475537
[TBL] [Abstract][Full Text] [Related]
15. Multidrug resistance-associated protein: a protein distinct from P-glycoprotein involved in cytotoxic drug expulsion.
Barrand MA; Bagrij T; Neo SY
Gen Pharmacol; 1997 May; 28(5):639-45. PubMed ID: 9184795
[TBL] [Abstract][Full Text] [Related]
16. P-glycoprotein expression is associated with FDG uptake and cell differentiation in patients with untreated lung cancer.
Higashi K; Ueda Y; Ikeda R; Kodama Y; Guo J; Matsunari I; Oguchi M; Tonami H; Katsuda S; Yamamoto I
Nucl Med Commun; 2004 Jan; 25(1):19-27. PubMed ID: 15061261
[TBL] [Abstract][Full Text] [Related]
17. Reversal of multidrug resistance by methoxypolyethylene glycol-block-polycaprolactone diblock copolymers through the inhibition of P-glycoprotein function.
Elamanchili P; McEachern C; Burt H
J Pharm Sci; 2009 Mar; 98(3):945-58. PubMed ID: 18623213
[TBL] [Abstract][Full Text] [Related]
18. A possibility to overcome P-glycoprotein (PGP)-mediated multidrug resistance by antibody-targeted drugs conjugated to N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer carrier.
St'astný M; Strohalm J; Plocová D; Ulbrich K; Ríhová B
Eur J Cancer; 1999 Mar; 35(3):459-66. PubMed ID: 10448300
[TBL] [Abstract][Full Text] [Related]
19. A polypeptide based podophyllotoxin conjugate for the treatment of multi drug resistant breast cancer with enhanced efficiency and minimal toxicity.
Zhou H; Lv S; Zhang D; Deng M; Zhang X; Tang Z; Chen X
Acta Biomater; 2018 Jun; 73():388-399. PubMed ID: 29694920
[TBL] [Abstract][Full Text] [Related]
20. The effect of survivin on multidrug resistance mediated by P-glycoprotein in MCF-7 and its adriamycin resistant cells.
Liu F; Xie ZH; Cai GP; Jiang YY
Biol Pharm Bull; 2007 Dec; 30(12):2279-83. PubMed ID: 18057712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
